IMMUCELL CORP ICCC
COM PAR · Common Stock · CUSIP 452525306
- SectorHealth care
- IndustryIn Vitro & In Vivo Diagnostic Substances
- HeadquartersPortland, ME
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 7.7m as of 2022-11-03, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $6.24.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 27 |
| Q4 2022 | 27 |
Biggest buyers
| DIMENSIONAL FUND ADVISORS LP | Added | +39.6k |
| VANGUARD GROUP INC | Added | +3.6k |
| MORGAN STANLEY | Added | +2.8k |
| Tower Research Capital LLC (TRC) | New | +1.3k |
| BlackRock Inc. | Added | +324 |
| BANK OF AMERICA CORP /DE/ | Added | +6 |
Biggest sellers
| Prosperity Planning, Inc. | Sold out | -16.0k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -12.1k |
| Perritt Capital Management Inc | Reduced | -6.5k |
| FLAGSHIP HARBOR ADVISORS, LLC | Reduced | -2.0k |
| NORTHERN TRUST CORP | Reduced | -222 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -53 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Knudsen Ejnar A III
13D · may seek influence
filed 2025-11-20
Stated purposeAll shares held by the Reporting Person are held by the Reporting Person for investment purposes. The Reporting Person currently has no plans or proposals that relate to, or would result in, any of the matters described in subsections (a) through (j) of Item 4 of the instructions to Schedule 13D. Full filing |
9.2% |
Insider purchases and sales in Q4 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 1 | $8.0k | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
None reported in Q4 2022.
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| VANGUARD GROUP INC 0.00% of their portfolio | 206.3k $1.3m | Added +3.6k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 125.5k $765.0k | Reduced -12.1k |
| Bleichroeder LP 0.13% of their portfolio | 101.6k $619.7k | Unchanged |
| Cresset Asset Management, LLC 0.01% of their portfolio | 96.4k $721.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 76.9k $468.9k | Added +2.8k |
| SHUFRO ROSE & CO LLC 0.03% of their portfolio | 62.4k $380.7k | Unchanged |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 62.2k $381.0k | Added +39.6k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 38.1k $233.0k | Reduced -53 |
| Overbrook Management Corp 0.06% of their portfolio | 35.5k $216.7k | Unchanged |
| Strategic Financial Services, Inc. 0.02% of their portfolio | 31.0k $189.7k | Unchanged |
| Perritt Capital Management Inc 0.10% of their portfolio | 30.0k $183.0k | Reduced -6.5k |
| HighTower Advisors, LLC 0.00% of their portfolio | 21.4k $131.0k | Unchanged |
| WEALTH EFFECTS LLC 0.05% of their portfolio | 15.7k $95.5k | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 15.6k $95.1k | Added +324 |
| FLAGSHIP HARBOR ADVISORS, LLC 0.01% of their portfolio | 14.2k $86.8k | Reduced -2.0k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 12.4k $75.9k | Reduced -222 |
| Minerva Advisors LLC 0.05% of their portfolio | 12.0k $72.1k | Unchanged |
| Essex Financial Services, Inc. 0.01% of their portfolio | 11.0k $67.0k | Unchanged |
| HM PAYSON & CO 0.00% of their portfolio | 8.1k $49.8k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 2.0k $12.4k | Added +6 |
| UBS Group AG 0.00% of their portfolio | 1.5k $9.2k | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.3k $8.0k | New |
| US BANCORP \DE\ 0.00% of their portfolio | 600 $3.7k | Unchanged |
| Geneos Wealth Management Inc. 0.00% of their portfolio | 244 $1.5k | Unchanged |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio | 152 $927 | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 37 $226 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |